Data and analytics firm Health Catalyst's Q4 revenue fell

Health Catalyst

12/03/2026 21:21

Corrects KD table to show revenue and gross margin figures are company-wide results, not technology-sector figures

Overview

U.S. healthcare analytics firm's Q4 revenue fell 6% yr/yr

Q4 adjusted EBITDA rose sharply and beat analyst expectations

Company posted large net loss due to goodwill and intangible asset impairments

Outlook

Health Catalyst expects Q1 2026 revenue between $68 mln and $70 mln

Company sees Q1 2026 Adjusted EBITDA between $7 mln and $8 mln

Company is not providing full-year 2026 guidance due to ongoing internal review and CEO transition

Result Drivers

IMPAIRMENT CHARGES - Co said net loss was driven by impairment of goodwill and intangible assets following impairment indicators and quantitative tests

COST REDUCTIONS - Gross margin improved due to lower costs, especially in professional services

CLIENT RETENTION - Dollar-based retention rate fell to 93% from 102%, indicating reduced client spend or attrition

Company press release: ID:nGNX4tHzSS

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
$74.68 mln
Q4 Net Income
-$91.03 mln
Q4 Adjusted EBITDA
Beat
$13.79 mln
$13.18 mln (10 Analysts)
Q4 Adj. Gross Margin
53.5%


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 8 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the software peer group is "buy"

Wall Street's median 12-month price target for Health Catalyst Inc is $3.88, about 108.3% above its March 11 closing price of $1.86

The stock recently traded at 5 times the next 12-month earnings vs. a P/E of 9 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)